• 2020-05-05 05:53:22

8 medical devices have been newly notified as “drugs” by government of India. These devices will henceforth be closely regulated and monitored for safety and performance.

• 2019-11-15 03:04:06

In recent years, NMPA has mandated all applicants to manage qualification of their medical device suppliers. However, not all of supplier would like to reveal the confidential information to their customers regardless if they have already disclosed such information at the time of registration.

• 2019-11-15 03:03:19

In order to strengthen the quality control of software medical device products, the State Drug Administration has prepared the "Appendix Independent Software for Medical Device Manufacturing Quality Control Specifications (Draft for Comment)" and solicited public opinions.

• 2020-02-12 09:09:07

On December 31, 2018, the Vietnam Ministry of Health (MOH) issued Decree No. 169/2018/ND-CP amending and supplementing some articles of Decree No.36 on Medical Device Management and took effect from the date of signing.

• 2020-02-12 14:07:31

In November, MDA had issued three major guidance documents, two of them being revised editions. One of these two is the 3rd revised edition of Guidance Document for Change Notification for Registered Medical Device in Malaysia.

• 2020-02-12 14:04:30

MDA has recently released a new guidance document regarding the requirements for application of Certificate of Free Sale (CFS) for export only medical devices. There had been plenty of queries received by MDA on the application of CFS for various applications and as a first step, they have released this GD, specifically for export only medical devices.

• 2020-02-12 14:03:26

Starting January 2019, Medical Device Marketing Authorization License will be issued in electronic form. This is in accordance to PMK No. 62 year of 2017 Article 22, which stated that Marketing Authorization License will not require stamp and wet signature anymore.

• 2020-02-12 14:01:43

In early November, CMDE has published a draft guideline for the reprocessing validation and labeling for reusable medical devices: Part 1 (hereinafter referred to as the "Guidelines") which solicited opinions from the public.

• 2020-02-12 14:00:16

In early November, NMPA has issued a draft of the guideline entitled, “Biological Evaluation for Medical Device Part 1: General Principles (hereinafter referred to as “the Guideline”) and has sought comments from stakeholders.

• 2020-02-12 13:57:05

Obtaining market access in the Japanese medical device market may sometimes represent a bit of a challenge for foreign manufacturers, we can provide interested customers with the full spectrum of services required for a smooth access to the Japanese market.